The Innovator Awards recognize UCI researchers working to move UCI knowledge and discoveries to market

UC Irvine Beall Applied Innovation, with generous support from Don and Ken Beall, created the annual Innovator Awards to recognize UC Irvine researchers working actively to promote commercialization of university intellectual property, which supports industry growth and moves inventions from the lab to market to benefit humankind.

Early Career Innovator/Emerging Innovation of the Year:

Recognizes distinguished innovators who have demonstrated excellence in the early stage of their careers, or in the early stages of an innovation breakthrough, through a combined effort in outstanding research and innovation.

This Year’s Awardees:

EMERGING INNOVATION/EARLY CAREER INNOVATOR OF THE YEAR

Liangzhong (Shawn) Xiang, Ph.D.
Professor, Radiological Sciences
UC Irvine School of Medicine
Professor, Biomedical Engineering
UC Irvine Samueli School of Engineering

Click here to learn more on the UC Irvine Beall Applied Innovation website.

Bruce J. Tromberg, PhD, to Deliver School of Medicine’s Commencement Address

UC Irvine School of Medicine will celebrate its Class of 2026 MDs, residents, and fellows at commencement on Saturday, May 16, at 2 p.m. in the Bren Events Center. This is a ticketed event; anyone unable to attend in person can view the ceremony through the livestream link.

This year’s featured commencement speaker is Bruce J. Tromberg, PhD, director of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health, where he leads programs advancing engineering, physical science and computational technologies in biology and medicine. He also spearheaded the NIH’s Rapid Acceleration of Diagnostics (RADx Tech) initiative to expand COVID-19 testing and accelerate the development of innovative diagnostic and point-of-care technologies. His research focuses on optical and photonic technologies for biomedical imaging and therapy, including portable and wearable tools for real-time, noninvasive monitoring of tissue health.

Prior to joining NIH in 2019, Tromberg spent nearly three decades at UC Irvine, where he was a professor of surgery and biomedical engineering, director of the Beckman Laser Institute and Medical Clinic, and a co-founder of the Department of Biomedical Engineering. An internationally recognized leader in biophotonics, he has authored more than 450 publications, holds numerous patents, and has trained more than 100 students and fellows. He is also co-founder of the biophotonics company Modulim Inc., a member of the National Academies of Medicine and Engineering, and a fellow of multiple leading scientific organizations.

We look forward to welcoming Tromberg and celebrating the School of Medicine Class of 2026!

Click here to read the full UC Irvine School of Medicine announcement.

BERNARD CHOI NAMED DIRECTOR OF UC IRVINE BECKMAN LASER INSTITUTE & MEDICAL CLINIC

Biomedical Optical Imaging Scientist to Lead Premier Laser Research Institute

UC Irvine has appointed Dr. Bernard Choi as Director of Beckman Laser Institute & Medical Clinic, following a comprehensive national search. The appointment marks a new chapter for one of the world’s leading centers for biomedical photonics, laser medicine, and translational optical research.

A long-standing member of the UC Irvine research community, Dr. Choi has served as the Institute’s Interim Director for the past three years, guiding the team through a period of significant growth and scientific achievement. As Professor of Biomedical Engineering and Surgery, he bridges the School of Medicine and the Henry Samueli School of Engineering. His service as Associate Chair of Undergraduate Studies in Biomedical Engineering further reflects a deep and abiding dedication to the university’s educational mission.

“The next chapter of the Institute is about translation, moving new innovations in optical and photonic technologies out of the laboratory and impacting patient care,” said Dr. Choi. “That vision only succeeds if we are equally committed to the educators and trainees who will carry this field forward.”

Dr. Choi earned his B.S. in Biomedical Engineering from Northwestern University. He went on to complete both his M.S.E. and Ph.D. in Biomedical Engineering from the University of Texas at Austin.

At the core of Dr. Choi’s scientific mission is the development of in vivo optical imaging methods for monitoring biological tissues in both normal and diseased states. Dr. Choi’s group is internationally recognized for advancing laser speckle imaging (LSI) to monitor blood flow in real time, alongside complementary modalities such as spatial frequency domain imaging (SFDI). These techniques have been applied to intrasurgical monitoring, burn triage, hemorrhage monitoring, wound healing assessment, and cerebral blood flow measurement, establishing the Institute as a leader in translational biophotonics. His laboratory is world-renowned for pioneering work in optical clearing (the use of chemical agents to reduce the scattering properties of biological tissue). This technique enables high-resolution, three-dimensional optical imaging and opens new frontiers in understanding disease progression and response to novel therapies.

To date, Dr. Choi has authored 157 peer-reviewed publications and holds seven patents. He has secured competitive extramural funding from the National Institutes of Health (NIH), the National Science Foundation (NSF), the Department of Defense (DoD), the Defense Advanced Research Projects Agency (DARPA), and other federal sponsors.

Dr. Choi’s active research portfolio reflects a consistent ability to move optical science from the benchtop to the bedside. With NIH support, he is developing a wearable optical patch to continuously monitor tissue perfusion, blood oxygenation, and microvascular function in real time with broad implications for remote patient care and personalized medicine. Supported by the National Heart, Lung, and Blood Institute (NHLBI), Dr. Choi is also developing an optical monitoring device to improve real-time assessment of maternal and fetal health during pregnancy and childbirth, addressing a critical gap in modern medicine. This work extends to field-deployable applications in military medicine, emergency response, and pre-hospital care.

Dr. Choi is equally invested in education and workforce development. He is establishing a UC Irvine Core Optical Laboratory Resource (COLR), a hands-on training facility for scientists, engineers, and clinicians in fundamental and applied optics and photonics. As co-PI of the Access to Careers in Engineering and Sciences (ACES) program, he leads an eight-week summer initiative providing undergraduate students from Historically Black Colleges and Universities (HBCUs) with immersive research experiences and mentorship in biomedical engineering and optical medicine. He also co-directs the NIH-funded Innovative Programs to Enhance Research Training (IPERT) program and serves as co-Principal Investigator (co-PI) on the NSF Team Science for Integrated Biomedical Engineering and Social Science Training (BEST) graduate training program. As PI of the Air Force Office of Scientific Research (AFOSR)-funded Military Medical Photonics center at the Institute, he collaborates with researchers in translating optical science to military medicine.

As Director, Dr. Choi will oversee the Institute’s research portfolio, operations, educational programs, and strategic direction. He assumes leadership of an institution with a distinguished history of scientific excellence, interdisciplinary collaboration, and real-world clinical impact.

“For nearly four decades, the Institute has transformed the way light is used to understand, diagnose, and heal,” said Dr. Choi. “My priorities now are clear: accelerate the translation of optical science into patient care, strengthen biophotonics education at every level, and cultivate a strong network of supporters to sustain our life-changing work for decades to come.”

 

 

 

 

Lifestyle, dietary habits can contribute to early hair loss

Researchers learned about condition, how body responds to inflammation during COVID-19 pandemic, says UCI Health dermatologist

IN THE NEWS: The exact causes of hair loss are not fully known, but some researchers say lifestyle and dietary habits can bring on early onset of genetic hair loss. UCI Health board certified dermatologist Dr. Natasha Mesinkovska spoke with MarketWatch about some of the reasons people experience it.

“We learned a lot about hair loss through the pandemic, and then it highlighted how our body responds to inflammation.”

COVID-19 can also cause temporary hair shedding during and after infection.

Mesinkovska also says GLP-1s can trigger temporary hair loss due to rapid weight loss in people who don’t eat very much or very well while taking the medicines. In some cases, she encourages patients to slow down their weight loss by staying on a lower dose of the medicines.

Mesinkovska is a board-certified UCI Health dermatologist who specializes in the diagnosis and treatment of skin disorders, including skin cancer. Her research interests include alopecia and dermatitis and she is the author or co-author of many articles in peer-reviewed publications.

In addition, she is an investigator on several current clinical trials involving alopecia, atopic dermatitis, psoriasis and skin laxity. She is also an associate professor of dermatology and the vice chair for clinical research in the Department of Dermatology at UC Irvine School of Medicine. Mesinkovska also serves as the director of integrative dermatology at the Beckman Laser Institute and the chief scientific officer of the National Alopecia Areata Foundation.

About UCI Health

UCI Health, one of California’s largest academic health systems, is the clinical enterprise of the University of California, Irvine. The 1,461-bed system comprises its main campus UCI Health — Orange, its flagship hospital, the UCI Health — Irvine acute care hospital and medical campus, four hospitals and affiliated physicians of the UCI Health Community Network in Orange and Los Angeles counties and a network of ambulatory care centers across the region. UCI Health — Orange provides tertiary and quaternary care and is home to the only Orange County-based National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. Powered by UC Irvine, UCI Health serves 5.6 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on FacebookInstagramLinkedIn and X (formerly Twitter).

Click here or visit https://www.ucihealth.org/about-us/news/2026/04/hair-loss to full UCI Health news article.

A MESSAGE FROM VICE CHANCELLOR FOR RESEARCH AILEEN ANDERSON

Directorship of the Beckman Laser Institute & Medical Clinic (BLIMC)

I am pleased to announce the appointment of Professor Bernard Choi as the next director of the Beckman Laser Institute and Medical Clinic (BLIMC), a Special Research Program (SRP).

Professor Choi, a long-time member and researcher at BLIMC, has served as its Interim Director for the past 3 years. He holds joint appointments in the Departments of Surgery and Biomedical Engineering. He received his B.Sc. from Northwestern University, and his M.S.E. and Ph.D. in Biomedical Engineering from the University of Texas at Austin. Professor Choi’s research interests include the development and application of in vivo optical imaging methods and technologies for monitoring of biological tissues in normal and diseased states, and for novel therapy discovery. He also leads research efforts on the use of chemical agents to reduce the optical scattering of biological tissue.

The selection of Professor Choi as BLIMC director is the result of a national search. I wish to thank the committee members for their thoughtful consideration of the candidates, as well as the unique characteristics and needs of a major institute such as BLIMC. I eagerly await its next chapter. Please join me in congratulating Professor Choi on his new role.

Aileen Anderson, Ph.D.
Vice Chancellor for Research

 

 

 

 

Lilangi Ediriwickrema, MD, Elected to the NEI Council of Vision Editors Fellow Program

The National Eye Institute recently elected Lilangi Ediriwickrema, MD, to the Council of Vision Editors Fellow Program (CVEF).

Lilangi Ediriwickrema, MD, is a board-certified UCI Health ophthalmologist who specializes in ophthalmic plastic and reconstructive surgery, neuro-ophthalmology and orbital disease.

The National Eye Institute (NEI) worked with the editors-in-chief of 7 leading vision journals to create a two-year program, the Council of Vision Editors Fellowship, in which early-career vision scientists will learn about academic peer review, the publication process, and editorial board processes.

Ediriwickrema’s translational research interests include validating biomarkers of periocular disease. She has also been listed as a Top Doctor by Castle Connolly as well as a Physician of Excellence by the Orange County Medical Association.

As a dedicated faculty member of the UC Irvine Gavin Herbert Eye Institute, Ediriwickrema continues to advance our understanding of reconstructive eye surgery and various orbital eye diseases.

Click here to read announcement on the UC Irvine School of Medicine website.

Scientists discover a hidden cause of brain bleeding

Brain hemorrhages are a serious health problem that can lead to stroke, memory loss, and other long‑term brain damage. One common type of small brain bleeding is called a cerebral microbleed. These tiny bleeds happen when small amounts of blood leak from very small blood vessels in the brain.

Doctors often detect them during brain scans, especially in older adults or people with neurological diseases. For many years, scientists believed that these small brain bleeds were mainly caused by damaged or weakened blood vessels. However, new research suggests that another surprising factor may also play a role.

A team of scientists from the University of California, Irvine has discovered that aging red blood cells may contribute directly to the formation of these small brain hemorrhages. Their findings provide a new way of thinking about how brain bleeds develop.

The study was led by Dr. Mark Fisher and Dr. Xiangmin Xu and was published in the scientific journal Journal of Neuroinflammation.

Red blood cells are responsible for carrying oxygen throughout the body. They travel through blood vessels and deliver oxygen to tissues and organs, including the brain.

Normally, these cells are flexible and able to squeeze through very tiny blood vessels called capillaries. Capillaries are the smallest blood vessels in the body, and they play a critical role in supplying oxygen and nutrients to brain cells.

As red blood cells age, however, they can become damaged or less flexible. When this happens, they may not move smoothly through the narrow capillaries. Scientists have long known that aging cells can behave differently, but it was not clear whether this process could lead to brain bleeding.

To investigate this question, the researchers designed a series of experiments using mice. First, they created damaged red blood cells in the laboratory. They used a chemical called tert‑butyl hydroperoxide to stress the cells and simulate the type of damage that happens naturally as cells grow older in the body.

After altering the red blood cells, the scientists labeled them with a fluorescent dye so that they could easily track the cells once they were inside the brain.

The researchers then injected these marked red blood cells into mice and used advanced imaging techniques to observe what happened inside the brain’s blood vessels. The results were unexpected and important.

The damaged red blood cells became trapped inside the tiny capillaries of the brain. Because these cells were less flexible, they could not easily pass through the narrow vessels. Once they became stuck, the brain’s immune system reacted.

The brain contains special immune cells known as microglia. These cells act like the brain’s cleanup crew. Their job is to remove debris, damaged cells, and harmful substances in order to protect the brain. When the microglia detected the trapped red blood cells, they moved in to remove them.

However, during this process something unusual happened. As the microglia engulfed and cleared the damaged red blood cells, tiny areas of bleeding appeared in the surrounding brain tissue. In other words, the immune system’s attempt to clean up the damaged cells actually triggered small brain hemorrhages.

This discovery challenges the long‑standing idea that cerebral microbleeds happen only because blood vessels break down or become weak. Instead, the new findings suggest that aging red blood cells themselves may start the chain of events that leads to bleeding.

The research may help explain why certain groups of people are more likely to develop cerebral microbleeds. Older adults often have more aging or damaged red blood cells in circulation.

People with high blood pressure, stroke, or neurodegenerative diseases such as Alzheimer’s disease are also known to have a higher risk of small brain bleeds. The new findings suggest that problems with red blood cells could be one of the reasons for this increased risk.

Dr. Fisher explained that understanding the role of red blood cells could change how scientists think about brain diseases. If damaged blood cells are involved in triggering microbleeds, future treatments might focus not only on protecting blood vessels but also on preventing red blood cell damage or improving how the brain clears these cells safely.

The researchers plan to continue studying how the brain removes damaged cells from tiny blood vessels and how this process may be linked to different types of stroke. By learning more about these mechanisms, scientists hope to find ways to reduce the risk of brain hemorrhages.

This discovery represents an important step forward in understanding brain health. Small brain bleeds are linked to serious conditions such as stroke, dementia, and problems with memory or thinking. By uncovering a new cause of these bleeds, researchers are moving closer to developing better strategies to protect the brain, especially as people age.

Although more research is needed before new treatments are developed, the findings offer hope that future therapies could prevent or reduce brain hemorrhages in people who are at high risk.

If you care about stroke, please read studies about how to eat to prevent stroke, and diets high in flavonoids could help reduce stroke risk.

For more health information, please see recent studies about how Mediterranean diet could protect your brain health, and wild blueberries can benefit your heart and brain.

Copyright © 2026 Knowridge Science Report. All rights reserved.

Click here or visit https://bit.ly/knowridge-scientists-discover to read full article on Knowridge.com.

Fei Xia Named a Scialog Fellow

– Lori Brandt, UC Irvine Samueli School of Engineering

March 12, 2026 – Fei Xia, UC Irvine assistant professor of electrical engineering and computer science, has been selected as a Scialog Fellow by the Research Corporation for Science Advancement (RCSA). She is one of 50 Scialog Fellows — outstanding early to mid-career researchers from U.S. academic institutions – who are part of an initiative to develop innovative ideas through research, dialogue and collaboration.

Xia’s research focuses on developing next-generation optical microscopy and computational imaging frameworks to probe the brain and its microenvironment in vivo. By integrating innovations in imaging hardware, physics-based simulations and AI-driven computation, her lab aims to achieve higher spatiotemporal resolution, deeper penetration into brain tissue and more information-rich views of living brains. “These advances will help reveal the brain’s structure, dynamics and functional responses with unprecedented clarity,” said Xia.

As a Scialog Fellow, she will participate in the Scialog: Neurobiology and Changing Ecosystems program. The three-year series aims to create a dynamic community of early career scientists with diverse scientific expertise and perspectives – cell biology, genetics, neurophysiology, climate science, environmental chemistry, physical modeling, toxicology and other fields. It is sponsored by RCSA, Allen Family Philanthropies, the Frederick Gardner Cottrell Foundation and the Kavli Foundation. Together, they will develop collaborative research projects to explore neurobiological response to change and advance understanding of the brain’s chemistry, physiology and adaptation mechanisms that allow survival under environmental stress.

“This collaborative program will accelerate our efforts to develop next-generation optical microscopy to image dynamic processes in living systems,” said Xia. “I’m excited to exchange ideas, build new collaborations, and work together toward deeper insights into how the brain adapts to changing environments.”

Xia is also a faculty member of Beckman Laser Institute and Medical Clinic, UCI Center for Neural Circuit Mapping, UCI Institute for Memory Impairments and Neurological Disorders and the UCI Eddleman Quantum Institute.

Click here to read full article on the UC Irvine Samueli School of Engineering website.

 

UC Irvine physicist Howard Lee awarded Humboldt Research Fellowship to advance ultrafast nano-photonics

UC Irvine physicist Howard Lee awarded Humboldt Research Fellowship to advance ultrafast nano-photonics

Tatiana Overly | UC Irvine School of Physical Sciences

Professor Howard Lee of the UC Irvine Department of Physics & Astronomy has been awarded a Humboldt Research Fellowship from the Alexander von Humboldt Foundation. The fellowship will allow Lee to spend up to 18 months in Germany collaborating with Dr. Ferenc Krausz, winner of the 2023 Nobel Prize in Physics, at the Max Planck Institute of Quantum Optics in Munich. The partnership will significantly advance Lee’s research into ultrafast photonics by giving his group access to some of the world’s most sophisticated attosecond-level laser systems.

Lee’s research focuses on manipulating light at the nanoscale, an essential capability underlying modern technologies, from fiber-optic networks to biomedical optical devices. By exploring how light interacts with materials on attosecond timescales (one quintillionth of a second), his work aims to enable the ultrafast modulation needed for next-generation communication platforms, future optical computing, and the precision probing of complex biomolecules.

“Although my work isn’t directly in attosecond physics, we’re interested in expanding our capabilities and understanding, and applying ultrafast pulse techniques to the nanomaterials and nanostructures we study,” Lee said.

Only a handful of facilities worldwide can perform attosecond-level measurements due to the extreme precision required. Lee explained that combining his group’s expertise in meta-materials and nano-optics with the advanced ultrafast laser infrastructure in Germany creates a unique opportunity to probe optical and electronic behaviors that have never been observed.

“Prof. Ferenc Krausz is a pioneer in the field of attosecond photonics, which makes this collaboration so compelling.” said Lee. “By combining our unique materials and nanostructures with their world-leading expertise and advanced ultrafast laser systems, we are positioned to explore entirely new frontiers in physics.”

The Humboldt Research Fellowship program is part of the Global Minds Initiative Germany of the Federal Ministry of Research, Technology and Space, a cabinet-level ministry of the German government. 

Click here to read full article on the UC Irvine School of Physical Sciences website.

 

UC Irvine Researchers Secure NIH Grant to Develop Life-Saving Wearable Patch

Michelle Khine, Amir Rahmani, and Bernard Choi receive federal funding to build a smart, wearable device capable of detecting life-threatening blood loss before it becomes fatal, with a critical focus on real-time monitoring in the operating room.

Drs. Michelle Khine and Bernard Choi of UC Irvine Beckman Laser Institute & Medical Clinic and Dr. Amir Rahmani of the School of Nursing have been awarded a two-year $408,504 grant from the National Institute on Aging to develop a groundbreaking wearable patch that can monitor a patient’s blood flow and detect dangerous bleeding in real time, especially in the operating room on patients at high risk for hemorrhage.

Trauma is one of the leading causes of death worldwide, with a significant portion of those deaths caused by severe bleeding, or hemorrhage. Hemorrhagic shock is especially deadly, as the warning signs are often subtle and go undetected until a patient is already in critical condition.

Current monitoring tools in hospitals, operating rooms, and emergency settings are often bulky, invasive, or unable to catch early warning signs. The problem is compounded by racial disparities in trauma outcomes, where patients may receive delayed or less accurate care, as existing monitoring technologies do not perform equally well across all skin tones.

To address these challenges, Drs. Khine, Rahmani, and Choi are developing a novel, integrated, wearable hemodynamic platform designed for the early detection and management of hemorrhage. The device combines miniaturized sensor technologies, including Micro-Electro-Mechanical Systems (MEMS), laser speckle imaging, and diffuse optical spectroscopy. By integrating these technologies with machine learning algorithms, the patch can continuously monitor vital signs and blood flow, enabling faster and more accurate interventions.

“By developing a wearable technology that monitors vital signs and predicts the risk of bleeding – a preventable factor in many cases – our goal is to make early detection and intervention possible, potentially saving millions of lives,” said Bernard Choi, interim director of the Institute.

The project will advance in three major phases. First, the patch will undergo lab validation to confirm that the device can accurately track vital signs and blood loss indicators. Researchers will then build and refine a machine learning model using the data collected to identify early warning patterns. Finally, the device will be tested on patients in an operating room setting, particularly those at high risk for bleeding during or after surgery.

If successful, the technology could transform trauma care by providing a reliable, non-invasive, and comprehensive monitoring system capable of detecting hemorrhage at its earliest stages. By improving the speed and accuracy of medical interventions in the operating room and across care settings, this technology has the potential to save lives and advance emergency and trauma medicine.

Click here to learn more.